The agreement will enhance selling efforts for Hill-Rom’s product, The Vest Airway Clearance system, to both acute and long-term care facilities within the US.
Hill-Rom’s Vest system uses high-frequency chest wall oscillation technology (HFCWO) to provide both the patient and clinician with a safe, easy to use, and effective method of Airway Clearance therapy. HFCWO therapy is prescribed for patients with retained secretions as a result of either acute or chronic respiratory conditions.
Kim Dennis, group vice president of post acute care at Hill-Rom, said: “We believe this strategic alliance will enhance our focus on increasing awareness of the importance of Airway Clearance therapy in the treatment of respiratory conditions across the care continuum.”